Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIOngoingD-0551-2025

Drug recall · August 6, 2025

Lorazepam Injection recall

Why: Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25

Lots / codes

Lot # K24118, exp. date 10/31/2026

Quantity
382,775 1mL vials
Company
Hikma Pharmaceuticals USA Inc., Cherry Hill, NJ
Distribution
Distributed Nationwide in the USA
Initiated
July 22, 2025 · Voluntary: Firm initiated
Classified
July 31, 2025
Reported
August 6, 2025
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Lorazepam

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.